0001390478-16-000111.txt : 20160607
0001390478-16-000111.hdr.sgml : 20160607
20160607183624
ACCESSION NUMBER: 0001390478-16-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160601
FILED AS OF DATE: 20160607
DATE AS OF CHANGE: 20160607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galena Biopharma, Inc.
CENTRAL INDEX KEY: 0001390478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4640 SW MACADAM AVENUE
STREET 2: SUITE 270
CITY: PORTLAND
STATE: OR
ZIP: 97239
BUSINESS PHONE: 855 855 GALE
MAIL ADDRESS:
STREET 1: 4640 SW MACADAM AVENUE
STREET 2: SUITE 270
CITY: PORTLAND
STATE: OR
ZIP: 97239
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20110926
FORMER COMPANY:
FORMER CONFORMED NAME: GALENA BIOPHARMA, INC.
DATE OF NAME CHANGE: 20110922
FORMER COMPANY:
FORMER CONFORMED NAME: RXI PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20110921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dunlap Ryan
CENTRAL INDEX KEY: 0001554742
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33958
FILM NUMBER: 161702358
MAIL ADDRESS:
STREET 1: 310 N. STATE STREET, SUITE 208
CITY: LAKE OSWEGO
STATE: OR
ZIP: 97034
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-06-01
1
0001390478
Galena Biopharma, Inc.
GALE
0001554742
Dunlap Ryan
C/O GALENA BIOPHARMA, INC.
2000 CROW CANYON PL., SUITE 380
SAN RAMON
CA
94583
0
1
0
0
Former Chief Financial Officer
Common Stock
2016-06-01
4
M
0
31250
1.75
A
49952
D
Common Stock
2016-06-01
4
M
0
65625
1.85
A
115577
D
Common Stock
2016-06-01
4
M
0
30000
1.71
A
145577
D
Common Stock
2016-06-01
4
S
0
126875
2.18
D
18702
D
Stock Option
1.75
2016-06-01
4
M
0
31250
0
D
Common Stock
31250
95625
D
Stock Option
1.85
2016-06-01
4
M
0
65625
0
D
Common Stock
65625
30000
D
Stock Option
1.71
2016-06-01
4
M
0
30000
0
D
Common Stock
30000
0
D
The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.16 to $2.22 per share. The reporting person undertakes the provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The trades settled on June 6, 2016.
The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/15/15).
This stock option was subject to cancellation on June 29, 2016, which was 90 days after the Reporting person's consulting agreement ended with the Issuer.
The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (7/9/12).
The option vests on a quarterly basis over four years, commencing on the last day of the quarter after the date of grant (1/29/13).
Ryan M. Dunlap
2016-06-07